Search results
BenevolentAI and AstraZeneca discover novel heart failure target using AI
Proactive Investors· 1 day agoBenevolentAI (AMS:BAI, OTC:BAIVF) told investors it has reached an important milestone in its...
Jacob Rees-Mogg claims UK government 'downplayed' risks of AstraZeneca COVID vaccine
Yahoo News UK· 6 days agoRees Mogg made the claims on his GB News show. (Getty) SOPA Images via Getty Images Jacob Rees-Mogg...
The AstraZeneca vaccine – should you be worried?
Daily Telegraph· 5 days agoEarlier this week, the European Commission announced that the Covid-19 vaccine, developed as part of a collaboration between the British pharma company ...
AstraZeneca PLC (NASDAQ:AZN) Shares Sold by Wealthspire Advisors LLC
ETF DAILY NEWS· 4 days agoWealthspire Advisors LLC decreased its holdings in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 39.6% in the 4th quarter, according to its most recent Form 13F ...
AstraZeneca's COVID vaccine withdrawn—it was a victim of misinformation right to the end, researcher...
Medical Xpress· 7 days agoThis EU announcement was preceded by an application from AstraZeneca on March 27, 2024, to withdraw...
Blackstone unearths Uniquity Bio with $300M to explore Merck drug's I&I potential
FierceBiotech· 18 hours agoWhat a time to be launching a new biotech focused on inflammation and immunology. Uniquity Bio is...
Eli Lilly’s and AstraZeneca’s Former Head of Research Dr. Jan Lundberg Elected as a New Board Member
Digital Journal· 19 hours agoProfessor Jan Lundberg has more than 25 years of experience from leading positions in global pharmaceutical companies, including as global head of research at Astra and then AstraZeneca ...
AstraZeneca pulls its COVID-19 vaccine from Europe
Boston Herald· 6 days agoThe pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator....
Expert reaction: AstraZeneca withdraws its COVID-19 vaccine
Cosmos· 5 days agoAstraZeneca developed the first vaccine for COVID-19, beating the competition, but this week they’ve...
KRAS inhibitors: The next frontier beckons
Pharmaceutical Technology via Yahoo Finance· 1 hour ago[You] would now involve the 40% of patients who were earlier neglected or ignored in these trials,” Azmi adds. Amgen and BMS are not the only companies...
